Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Danjing Luo, Qiulu Zhong & Xiaodong Zhu. (2023) The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis. Cancer Biology & Therapy 24:1.
Read now
Read now
Articles from other publishers (17)
Renxian Xie, Qingxin Cai, Tong Chen, Hongxin Huang & Chuangzhen Chen. (2024) Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma. Frontiers in Oncology 14.
Crossref
Crossref
Julian Mangesius, Katharina Hörmandinger, Robert Jäger, Sergej Skvortsov, Marlen Plankensteiner, Martin Maffei, Thomas Seppi, Daniel Dejaco, Matthias Santer, Manuel Sarcletti & Ute Ganswindt. (2023) Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma. Cancers 15:14, pages 3594.
Crossref
Crossref
Michael D. Chuong, Russell F. Palm, Michael C. Tjong, Daniel E. Hyer & Amar U. Kishan. (2023) Advances in MRI-Guided Radiation Therapy. Surgical Oncology Clinics of North America 32:3, pages 599-615.
Crossref
Crossref
Ugur Selek, Duygu Sezen, Nulifer Kilic Durankus, Yucel Saglam & Yasemin Bolukbasi. 2023. MR Linac Radiotherapy - A New Personalized Treatment Approach. MR Linac Radiotherapy - A New Personalized Treatment Approach
237
270
.
Cheng Chen, Bangwei Zeng, Dan Xue, Rongxiang Cao, Siqin Liao, Yong Yang, Zhihua Li, Mingqiang Kang, Chun Chen & Benhua Xu. (2022) Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial. BMJ Open 12:10, pages e060619.
Crossref
Crossref
Pavel Vítek & Jiří Kubeš. (2022) What are the benefits of proton beam therapy for esophageal cancer?. Onkologie 16:5, pages 239-245.
Crossref
Crossref
Li-Hua Liu, Mao-Hui Yan, Yu-Peng Di, Zhi-Guang Fu, Xiao-Dan Zhang & Hong-Qi Li. (2022)
Comparison of involved-field intensity-modulated radiotherapy combined with S-1
vs
radiotherapy alone for elderly patients with esophageal cancer
. World Journal of Clinical Cases 10:21, pages 7365-7375.
Crossref
Crossref
Yujin Xu, Baiqiang Dong, Weiguo Zhu, Jiancheng Li, Rong Huang, Zongwen Sun, Xinmei Yang, Liping Liu, Han He, Zhongxing Liao, Ni Guan, Yue Kong, Wanwei Wang, Jianxiang Chen, Huijuan He, Guoqin Qiu, Ming Zeng, Juan Pu, Wangyuan Hu, Yong Bao, Zhigang Liu, Jun Ma, Hao Jiang, Xianghui Du, Jin Hu, Tingting Zhuang, Jing Cai, Jin Huang, Hua Tao, Yuan Liu, Xiaodong Liang, Juying Zhou, Guangzhou Tao, Xiao Zheng & Ming Chen. (2022) A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma. Clinical Cancer Research 28:9, pages 1792-1799.
Crossref
Crossref
He-San Luo, Ying-Ying Chen, Wei-Zhen Huang, Sheng-Xi Wu, Shao-Fu Huang, Hong-Yao Xu, Ren-Liang Xue, Ze-Sen Du, Xu-Yuan Li, Lian-Xin Lin & He-Cheng Huang. (2021) Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiation Oncology 16:1.
Crossref
Crossref
Xun Wu, Xingsheng Hu, Junru Chen & Lang He. (2021) A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy. Radiation Oncology 16:1.
Crossref
Crossref
Maarten C. C. M. Hulshof, Elisabeth D. Geijsen, Tom Rozema, Vera Oppedijk, Jeroen Buijsen, Karen J. Neelis, Joost J. M. E. Nuyttens, Maurice J. C. van der Sangen, Paul M. Jeene, Jannie G. Reinders, Mark I. van Berge Henegouwen, Adriana Thano, Jeanin E. van Hooft, Hanneke W. M. van Laarhoven & Ate van der Gaast. (2021) Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study). Journal of Clinical Oncology 39:25, pages 2816-2824.
Crossref
Crossref
Ronald Chow, Michael Lock, Sangjune Laurence Lee, Simon S. Lo & Charles B. SimoneIIII. (2021) Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”. Frontiers in Oncology 11.
Crossref
Crossref
Sangjune Laurence Lee, Michael Bassetti, Gert J. Meijer & Stella Mook. (2021) Review of MR-Guided Radiotherapy for Esophageal Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Hamid Yimam Hassen, Mohammed Ahmed Teka & Adamu Addisse. (2021) Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort Study. Frontiers in Oncology 10.
Crossref
Crossref
Xin Sun, Lei Wang, Yang Wang, Jingjing Kang, Wei Jiang, Yu Men & Zhouguang Hui. (2020) High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
He-San Luo, He-Cheng Huang & Lian-Xing Lin. (2019) Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis. Radiation Oncology 14:1.
Crossref
Crossref
Ying Liu, Xinhua Wang, Shuang Zeng, Xiane Zhang, Jimin Zhao, Xiaoyan Zhang, Xinhuan Chen, Wanjing Yang, Yili Yang, Ziming Dong, Jingyu Zhu, Xin Xu & Fang Tian. (2018) The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref